4502.T
4502.T
JP3463000004
TAKEDA PHARMACEUTICAL CO LTD
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
9.33T EUR
8.14T EUR
9.3T EUR
7.64T EUR
Enterprise Value
14.31T EUR
12.62T EUR
13.59T EUR
11.84T EUR
Valuation Multiples
Trailing P/E
--
--
--
35.34x
Forward P/E
41.62x
--
--
--
Price to Sales
2.02x
1.76x
2.06x
2.24x
Price to Book
1.22x
1.08x
1.25x
1x
EV/Revenue
3.1x
2.73x
3.02x
3.47x
EV/EBITDA
11.45x
19.56x
19.49x
10.26x
Price to FCF (P/FCF)
17.24x
16.73x
19.12x
16.03x
EV/FCF
26.43x
25.93x
27.92x
24.84x
FCF Yield
5.8%
5.98%
5.23%
6.24%
ende